428
Views
0
CrossRef citations to date
0
Altmetric
News & Views

Ask the Experts: Pharmacogenomics and Genome-Wide Association Studies

Pages 365-368 | Published online: 25 Feb 2013
 

Abstract

Hakon Hakonarson is an associate professor of pediatrics at The University of Pennsylvania School of Medicine (PA, USA). He is a physician–scientist and director of The Children‘s Hospital of Philadelphia‘s Center for Applied Genomics, a high-throughput highly automated genotyping facility founded to identify the genetic causes of complex medical disorders in children, such as autism and cancer, with the objective of developing new therapies. The Center represents a US$40 million commitment from The Children‘s Hospital of Philadelphia to genotype approximately 100,000 children; a research undertaking that has gained nationwide attention, including news features in prestigious newspapers and scientific journals. Hakonarson has an extensive track record in human genetics and has developed an international reputation among his peers. He has served previously in several senior posts in the biopharmaceutical industry and has been the principal and coprincipal investigator on several NIH-sponsored grants. He has published numerous high-impact papers on genomic discoveries and their translations in some of the most prestigious scientific medical journals. Time Magazine listed Hakonarson‘s autism gene discovery, reported in Nature in 2009, among the top ten medical breakthroughs of that year. With over 15 years of experience in pioneering genomics and pharmacogenomics research, as well as genome-wide mapping and association studies, Hakonarson has intimate knowledge of the complexities of large-scale genomics projects and has put together the necessary infrastructure and workflow processes to unravel these complexities.

Financial & competing interests disclosure

H Hakonarson founded a start-up company in 2012 to investigate metabotropic glutamate receptors in Attention-deficit/hyperactivity disorder. He has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.